Jamy Ard, MD, FTOS, can be reached at [email protected]
These medications are vastly different, despite being in the same medication class, agrees Jodie Pepin, Pharm.D., clinical pharmacy program manager at Harbor Health in Round Rock, Texas
Variation in Payer Coverage for Weight Loss Medications While GLP-1 medications for the treatment of type 2 diabetes are generally covered by insurers, coverage for weight loss purposes varies considerably by payer
Amylin, a peptide hormone composed of 37 amino acids, operates in conjunction with GLP-1 to achieve similar objectives using unique yet complementary pathways that include enhanced inhibition of glucagon secretion, further modulation of gastric emptying by vagal nerve activity, and activation of area postrema receptors in the brain stem to induce satiety by pathways that are relatively independent of GLP-1 pathways